AAPL333.26+5.76 (+1.76%) ▲|ABBV254.39+10.28 (+4.21%) ▲|ABT98.83+9.56 (+10.71%) ▲|ACN144.61+7.59 (+5.54%) ▲|ADBE235.31+10.75 (+4.79%) ▲|AMAT560.93-18.50 (-3.19%) ▼|AMD500.94-28.20 (-5.33%) ▼|AMGN371.58+13.26 (+3.70%) ▲|AMT168.92+0.29 (+0.17%) ▲|AMZN249.89-5.07 (-1.99%) ▼|AVGO374.45-19.83 (-5.03%) ▼|AXP361.57+3.13 (+0.87%) ▲|BA214.34-3.78 (-1.73%) ▼|BAC61.49-0.10 (-0.16%) ▼|BKNG184.61+1.81 (+0.99%) ▲|BLK1,087.05-6.35 (-0.58%) ▼|BMY60.51+1.79 (+3.05%) ▲|BNY160.86-1.49 (-0.92%) ▼|BRK-B493.12+4.77 (+0.98%) ▲|C131.71-3.18 (-2.36%) ▼|CAT877.17-37.13 (-4.06%) ▼|CL94.07+2.60 (+2.84%) ▲|CMCSA24.10+0.61 (+2.60%) ▲|COF211.93+3.04 (+1.46%) ▲|COP112.84+1.38 (+1.24%) ▲|COST945.57+29.03 (+3.17%) ▲|CRM172.68+5.68 (+3.40%) ▲|CSCO109.66-2.11 (-1.89%) ▼|CVS106.50+0.59 (+0.56%) ▲|CVX183.86+2.26 (+1.24%) ▲|DE598.97+9.49 (+1.61%) ▲|DHR205.01+4.22 (+2.10%) ▲|DIS99.71+2.56 (+2.64%) ▲|DUK126.11+1.77 (+1.42%) ▲|EMR139.08+2.83 (+2.08%) ▲|FDX318.20+4.78 (+1.53%) ▲|GD368.82+3.19 (+0.87%) ▲|GE345.73-14.62 (-4.06%) ▼|GEV1,036.22-19.06 (-1.81%) ▼|GILD136.30+4.60 (+3.49%) ▲|GM77.72+0.08 (+0.10%) ▲|GOOG353.81-16.40 (-4.43%) ▼|GOOGL354.46-16.46 (-4.44%) ▼|GS1,095.46-56.61 (-4.91%) ▼|HD348.02+6.58 (+1.93%) ▲|HON226.33+3.49 (+1.57%) ▲|IBM219.05+7.85 (+3.72%) ▲|INTC96.98-6.01 (-5.84%) ▼|INTU294.79+15.09 (+5.40%) ▲|ISRG402.33+13.36 (+3.43%) ▲|JNJ249.97+2.95 (+1.19%) ▲|JPM343.15-3.76 (-1.08%) ▼|KO84.92+2.47 (+3.00%) ▲|LIN520.74+6.59 (+1.28%) ▲|LLY1,169.17+12.54 (+1.08%) ▲|LMT513.52-0.94 (-0.18%) ▼|LOW216.16+6.50 (+3.10%) ▲|LRCX320.96-14.47 (-4.31%) ▼|MA551.54+16.33 (+3.05%) ▲|MCD273.46+8.51 (+3.21%) ▲|MDLZ61.42+2.70 (+4.60%) ▲|MDT83.56+3.09 (+3.84%) ▲|META664.54-16.77 (-2.46%) ▼|MMM161.77+1.24 (+0.77%) ▲|MO73.03+2.51 (+3.56%) ▲|MRK127.63+4.02 (+3.25%) ▲|MS218.37-10.18 (-4.45%) ▼|MSFT401.10+5.47 (+1.38%) ▲|MU853.20-51.08 (-5.65%) ▼|NEE89.35+0.25 (+0.28%) ▲|NFLX74.35+0.67 (+0.91%) ▲|NKE44.57+1.80 (+4.21%) ▲|NOW104.01-0.72 (-0.69%) ▼|NVDA207.40-5.10 (-2.40%) ▼|ORCL124.21-8.28 (-6.25%) ▼|PEP139.43+4.03 (+2.98%) ▲|PFE25.14+0.32 (+1.29%) ▲|PG151.50+3.45 (+2.33%) ▲|PLTR134.44+0.68 (+0.51%) ▲|PM189.84+8.96 (+4.95%) ▲|QCOM170.61-7.37 (-4.14%) ▼|RTX194.36-1.53 (-0.78%) ▼|SBUX108.37+3.26 (+3.10%) ▲|SCHW102.80+0.01 (+0.01%) ▲|SO96.07+1.47 (+1.55%) ▲|SPG228.49+6.48 (+2.92%) ▲|T21.98+0.55 (+2.57%) ▲|TMO543.19+7.90 (+1.48%) ▲|TMUS192.85+5.23 (+2.79%) ▲|TSLA391.06-3.40 (-0.86%) ▼|TXN291.22-9.97 (-3.31%) ▼|UBER74.04+1.37 (+1.89%) ▲|UNH423.38+4.86 (+1.16%) ▲|UNP299.42+11.06 (+3.84%) ▲|UPS117.18+4.24 (+3.75%) ▲|USB64.01+1.00 (+1.59%) ▲|V365.14+10.00 (+2.82%) ▲|VZ43.88+1.05 (+2.45%) ▲|WFC88.07+0.56 (+0.64%) ▲|WMT114.95+2.42 (+2.15%) ▲|XOM145.95+1.44 (+1.00%) ▲|AAPL333.26+5.76 (+1.76%) ▲|ABBV254.39+10.28 (+4.21%) ▲|ABT98.83+9.56 (+10.71%) ▲|ACN144.61+7.59 (+5.54%) ▲|ADBE235.31+10.75 (+4.79%) ▲|AMAT560.93-18.50 (-3.19%) ▼|AMD500.94-28.20 (-5.33%) ▼|AMGN371.58+13.26 (+3.70%) ▲|AMT168.92+0.29 (+0.17%) ▲|AMZN249.89-5.07 (-1.99%) ▼|AVGO374.45-19.83 (-5.03%) ▼|AXP361.57+3.13 (+0.87%) ▲|BA214.34-3.78 (-1.73%) ▼|BAC61.49-0.10 (-0.16%) ▼|BKNG184.61+1.81 (+0.99%) ▲|BLK1,087.05-6.35 (-0.58%) ▼|BMY60.51+1.79 (+3.05%) ▲|BNY160.86-1.49 (-0.92%) ▼|BRK-B493.12+4.77 (+0.98%) ▲|C131.71-3.18 (-2.36%) ▼|CAT877.17-37.13 (-4.06%) ▼|CL94.07+2.60 (+2.84%) ▲|CMCSA24.10+0.61 (+2.60%) ▲|COF211.93+3.04 (+1.46%) ▲|COP112.84+1.38 (+1.24%) ▲|COST945.57+29.03 (+3.17%) ▲|CRM172.68+5.68 (+3.40%) ▲|CSCO109.66-2.11 (-1.89%) ▼|CVS106.50+0.59 (+0.56%) ▲|CVX183.86+2.26 (+1.24%) ▲|DE598.97+9.49 (+1.61%) ▲|DHR205.01+4.22 (+2.10%) ▲|DIS99.71+2.56 (+2.64%) ▲|DUK126.11+1.77 (+1.42%) ▲|EMR139.08+2.83 (+2.08%) ▲|FDX318.20+4.78 (+1.53%) ▲|GD368.82+3.19 (+0.87%) ▲|GE345.73-14.62 (-4.06%) ▼|GEV1,036.22-19.06 (-1.81%) ▼|GILD136.30+4.60 (+3.49%) ▲|GM77.72+0.08 (+0.10%) ▲|GOOG353.81-16.40 (-4.43%) ▼|GOOGL354.46-16.46 (-4.44%) ▼|GS1,095.46-56.61 (-4.91%) ▼|HD348.02+6.58 (+1.93%) ▲|HON226.33+3.49 (+1.57%) ▲|IBM219.05+7.85 (+3.72%) ▲|INTC96.98-6.01 (-5.84%) ▼|INTU294.79+15.09 (+5.40%) ▲|ISRG402.33+13.36 (+3.43%) ▲|JNJ249.97+2.95 (+1.19%) ▲|JPM343.15-3.76 (-1.08%) ▼|KO84.92+2.47 (+3.00%) ▲|LIN520.74+6.59 (+1.28%) ▲|LLY1,169.17+12.54 (+1.08%) ▲|LMT513.52-0.94 (-0.18%) ▼|LOW216.16+6.50 (+3.10%) ▲|LRCX320.96-14.47 (-4.31%) ▼|MA551.54+16.33 (+3.05%) ▲|MCD273.46+8.51 (+3.21%) ▲|MDLZ61.42+2.70 (+4.60%) ▲|MDT83.56+3.09 (+3.84%) ▲|META664.54-16.77 (-2.46%) ▼|MMM161.77+1.24 (+0.77%) ▲|MO73.03+2.51 (+3.56%) ▲|MRK127.63+4.02 (+3.25%) ▲|MS218.37-10.18 (-4.45%) ▼|MSFT401.10+5.47 (+1.38%) ▲|MU853.20-51.08 (-5.65%) ▼|NEE89.35+0.25 (+0.28%) ▲|NFLX74.35+0.67 (+0.91%) ▲|NKE44.57+1.80 (+4.21%) ▲|NOW104.01-0.72 (-0.69%) ▼|NVDA207.40-5.10 (-2.40%) ▼|ORCL124.21-8.28 (-6.25%) ▼|PEP139.43+4.03 (+2.98%) ▲|PFE25.14+0.32 (+1.29%) ▲|PG151.50+3.45 (+2.33%) ▲|PLTR134.44+0.68 (+0.51%) ▲|PM189.84+8.96 (+4.95%) ▲|QCOM170.61-7.37 (-4.14%) ▼|RTX194.36-1.53 (-0.78%) ▼|SBUX108.37+3.26 (+3.10%) ▲|SCHW102.80+0.01 (+0.01%) ▲|SO96.07+1.47 (+1.55%) ▲|SPG228.49+6.48 (+2.92%) ▲|T21.98+0.55 (+2.57%) ▲|TMO543.19+7.90 (+1.48%) ▲|TMUS192.85+5.23 (+2.79%) ▲|TSLA391.06-3.40 (-0.86%) ▼|TXN291.22-9.97 (-3.31%) ▼|UBER74.04+1.37 (+1.89%) ▲|UNH423.38+4.86 (+1.16%) ▲|UNP299.42+11.06 (+3.84%) ▲|UPS117.18+4.24 (+3.75%) ▲|USB64.01+1.00 (+1.59%) ▲|V365.14+10.00 (+2.82%) ▲|VZ43.88+1.05 (+2.45%) ▲|WFC88.07+0.56 (+0.64%) ▲|WMT114.95+2.42 (+2.15%) ▲|XOM145.95+1.44 (+1.00%) ▲|
25.2 C
New York
Friday, July 17, 2026

Tag: development

Kite Realty Group Announces Pricing of $300 Million Senior Notes Offering

INDIANAPOLIS, June 17, 2025 (GLOBE NEWSWIRE) -- Kite Realty Group Trust (NYSE: KRG) (the “Company”) announced today that, on June 17, 2025, its operating partnership, Kite Realty Group, L.P. (the “Operating Partnership”), priced an offering of $300 million aggregate principal amount of 5.200% Senior Notes due 2032 (the “Notes”) in an underwritten public offering. The Notes will be issued at 99.513% of par value with a yield to maturity of 5.281%. Interest on the Notes is payable semi-annually on February 15 and August 15 of each year, beginning on February 15, 2026. The offering is expected to close on June 27, 2025, subject to the satisfaction of customary closing conditions.

Biomea Fusion Announces Proposed Public Offering of Securities

REDWOOD CITY, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, announced today that it has commenced an underwritten public offering of shares of its common stock and accompanying warrants to purchase shares of its common stock (or pre-funded warrants in lieu thereof) and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock and accompanying warrants to purchase shares of its common stock (or pre-funded warrants in lieu thereof). In addition, Biomea intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock and pre-funded warrants offered in the public offering. All of the shares, pre-funded warrants and accompanying common stock warrants to be sold in the proposed offering are to be sold by Biomea.

Talos Energy Announces Enhanced Corporate Strategy

HOUSTON, June 17, 2025 /PRNewswire/ -- Talos Energy Inc. ("Talos" or the "Company") (NYSE: TALO) today announced its enhanced corporate strategy designed to position...

Mixed Martial Arts Group Limited Announces Pricing of $5.0 Million Underwritten Offering

New York, NY, June 17, 2025 (GLOBE NEWSWIRE) -- Mixed Martial Arts Group Limited (NYSE American: MMA) (“MMA” or the “Company”), announced today the pricing of an underwritten public offering of 6,578,948 ordinary shares (or pre-funded warrants to purchase ordinary shares in lieu thereof) at a public offering price of $0.76 per share (the “Offering”). The aggregate gross proceeds to MMA from the Offering are expected to be approximately $5.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by MMA. The Offering is expected to close on June 18, 2025, subject to the satisfaction of customary closing conditions.

Royal Farms Launches Chickenpalooza 2025 with Sky-High Flavor and Community Impact

Crave bigger. Drop in. Give back.
Crave bigger. Drop in. Give back.

Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer and Announces Timing for the Next Update from the CRDF-004 Trial in First-Line RAS-mutated...

– Veteran executive with over 20 years of oncology leadership and clinical experience with proven track record of success in bringing development candidates through late-stage clinical development –

Applied Therapeutics Announces Key Leadership Appointments

NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced key appointments to its executive leadership team with the promotions of Evan Bailey, MD, to Chief Medical Officer (CMO), effective June 15, 2025, and Dottie Caplan to Executive Vice President (EVP), Patient Advocacy and Government Affairs.

Explore Changping: Where Ming Dynasty Heritage Meets Modern Adventure

CHANGPING, China, June 18, 2025 /PRNewswire/ -- On June 14, the Ming Dynasty Culture Forum 2025 opened at the Ming Culture International Exchange Center...

YUL MONTRÉAL-TRUDEAU INTERNATIONAL AIRPORT: SUMMER SEASON TRAVEL TIPS AND MITIGATION MEASURES

MONTRÉAL, June 17, 2025 /CNW/ - With significant passenger traffic at YUL Montréal-Trudeau International Airport and many summer destinations awaiting travellers, ADM Aéroports de Montréal...

Registration Now Open for Campus Takeover Hosted by Syracuse University and Gen.G

Two-day conference in September will feature first-ever national Esports Business Case Study Competition along with industry and career panels LOS ANGELES and SYRACUSE, N.Y.,...

Alto Adige Wines, Vintage 2024: Exceptional in Vineyard and Cellar

Lighter, elegant and modern wines emerge after a challenging growing season in Alto Adige BOLZANO, Italy, June 17, 2025 /PRNewswire/ -- With the release on the...

Human Longevity, Inc. Expands Pancreatic Cancer Prevention Commitment with $1 Million Pledge for Qualified Members

SOUTH SAN FRANCISCO, Calif., June 17, 2025 /PRNewswire/ -- Human Longevity, Inc. (HLI), a global leader in precision medicine and proactive health, today announced...

DRML Miner Launches XRP ETF on Toronto Stock Exchange and Expands Cloud Mining Opportunities

Canadian Debut of DRML Miner XRP ETF Set for June 18, 2025, Alongside New Cloud Mining Contracts Offering Up to $6,000 Daily in XRP
Canadian Debut of DRML Miner XRP ETF Set for June 18, 2025, Alongside New Cloud Mining Contracts Offering Up to $6,000 Daily in XRP

BioAegis Therapeutics Receives FDA Fast Track Designation for Lead Product, Recombinant Human Gelsolin, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

Fast Track status enables expedited regulatory review timelines and supports the development of recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDevelopment